Today's Top 20 Gastroenterology and Endoscopy Stories
-
Exact Sciences pivots to telemedicine in a COVID-19 world — 4 quotes on the company's Q1 performance
Exact Sciences posted first-quarter 2020 revenues of $347.8 million, a 114 percent year-over-year increase, but still realized a net loss of $105.7 million, or $0.71 per share. -
5 top-read stories in GI this week — May 7
Here are the five most-read Becker's ASC Review articles for gastroenterologists the week of May 4-8: -
Exact Sciences exceeds revenue estimates but posts Q1 loss — 5 insights
Exact Sciences posted first-quarter 2020 revenues of $347.8 million, a 114 percent year-over-year increase. -
Colorado GI practice's surgical schedules begin to 'fill up'
The administrator of a Colorado GI practice said the practice is starting to see its elective procedure volumes return, in a May 7 article in the Greeley Tribune. -
How Cologuard compares to FIT & more: 6 GI industry key notes
Here are six updates from gastroenterology companies and practices from the past week: -
Motus GI gains new patent for flagship colonoscopy prep system — 3 quick points
Motus GI secured a U.S. patent for its Pure-Vu System's sensing technology and suction control features. -
Cologuard may be more applicable option for Medicare population than FIT — 4 insight
Medicare beneficiaries may engage with a multi-target stool DNA test better than a fecal immunochemical test, according to a study debuted digitally at Digestive Disease Week 2020. -
New York system relocates GI services to new outpatient clinic
Thompson Health Gastroenterology is relocating to a new outpatient clinic May 4, the Daily Messenger reports. -
AGA issues guideline on COVID-19 case management
The American Gastroenterological Association released a guideline on the consultative management of COVID-19 patients. -
Initial CRC blood test results show promise
CellMax Life released results from its U.S. study of the FirstSight blood test that revealed the test detected colorectal cancer with 100 percent sensitivity at 90 percent specificity. -
Gastroenterology group expects 30% of normal volumes in May — 3 details
Phoenix-based Arizona Digestive Health expects patient volumes in May will be just a fraction of what they were before the pandemic, gastroenterologist Paul Berggreen, MD, told Medscape Medical News. -
Merger forms new GI pharmaceutical company
RDD Pharma, Innovate Biopharmaceuticals and Naia Rare Diseases merged and formed 9 Meters Biopharma, which will develop treatments for orphan diseases and unmet needs in gastroenterology. -
5 top-read stories in GI this week — April 30
Here are the five most-read Becker's ASC Review articles for gastroenterologists the week of April 27-May 1: -
Liquid biopsy tests, conventional screening for cancer could present complete picture
A combination of liquid biopsy screening tests and conventional screening practices could present a more complete oncology picture, according to a study published in Science. -
Exact Sciences quarterly revenues hit $348M & more: 6 GI industry key notes
Here are six updates from gastroenterology companies and practices from the past week: -
Gastrologix, CRSG partner
Gastroenterology-focused group purchasing organization Gastrologix partnered with Clinical Research Strategy Group to facilitate discounted rates to CSRG's clinical trial management platform. -
AGA partners with EndoscopyNow app to create communication platform
The American Gastroenterological Association partnered with EndoscopyNow to provide AGA members access to a centralized platform with news, clinical data, procedural insights and product information. -
Exact Sciences to post $348M in Q1 revenue — 6 insights
Exact Sciences pre-announced some first quarter 2020 financial figures and will post $348 million in first quarter revenues. -
Guidelines for resuming elective endoscopy surgeries amid pandemic
The American Gastroenterological Association and the Digestive Health Physicians Association have drafted guidance for gastroenterologists to restart elective endoscopy procedures during the COVID-19 pandemic. -
Seasoned COO joins 24-physician gastroenterology practice
University Gastroenterology installed Jonathan Friedman as chief operating officer, the Providence Journal reports.